{"id":"doi:10.1001/jama.2023.12548","kind":"article","title":"Alzheimer Drug Lecanemab Gains Traditional FDA Approval","authors":["Emily Harris"],"author_count":1,"year":2023,"published":"2023-07-19","venue":"JAMA","cited_by":44,"doi":"10.1001/jama.2023.12548","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1001/jama.2023.12548","archive_url":"https://space-kitty.com/papers/doi:10.1001/jama.2023.12548","updated":null,"pmid":"37466999","pmcid":null,"openalex_id":"W4384663155","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"retracted":false,"peer_reviewed":null,"categories":["Alzheimer's disease research and treatments"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"neurodegeneration","name":"Alzheimer's, Parkinson's & Neurodegeneration","domain_slug":"medicine"}],"cited_in_dossiers":[]}